Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance.

Sandhu, Amneet; Kao, David; Mehler, Philip S; Haigney, Mark C P; Krantz, Mori J

Sandhu, Amneet; Kao, David; Mehler, Philip S; Haigney, Mark C P; Krantz, Mori J.

Afiliação

Sandhu A; Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, United States; Denver Health Medical Center, Cardiology Division, United States.
Kao D; Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, United States.
Mehler PS; Denver Health Medical Center, Cardiology Division, United States.
Haigney MC; Department of Medicine, Division of Cardiology, Uniform Services University of the Health Sciences, United States.
Krantz MJ; Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, United States; Denver Health Medical Center, Cardiology Division, United States. Electronic address: mkrantz@dhha.org.

Int J Cardiol ; 212: 360-3, 2016 Jun 01.

Article em En | MEDLINE | ID: mdl-27060723

Assuntos

Doenças Cardiovasculares/epidemiologia; Naloxona/efeitos adversos; Oxicodona/efeitos adversos; Tilidina/efeitos adversos; Doenças Cardiovasculares/induzido quimicamente; Combinação de Medicamentos; Humanos; Farmacovigilância; Organização Mundial da Saúde

Palavras-chave

Cardiovascular disorders; Naloxone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxicodona / Tilidina / Doenças Cardiovasculares / Naloxona Tipo de estudo: Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google